FDA Inspection
Minaris Regenerative Medicine, LLCMinaris Regenerative Medicine, LLC – FDA Inspection, Sep 25, 2023
Record Details
This FDA Inspection record concerns Minaris Regenerative Medicine, LLC, with an inspection on September 25, 2023, issued by the New Jersey District Office.
- Inspection Date
- September 25, 2023
View Company Profile
ID · 67457ed3-fd4a-4ea8-9ff2-b34c5e919157
Inspection Facts
- Inspection number
- 1224145
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Minaris Regenerative Medicine, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2025 | Not classified | New Jersey District Office | Human Cellular, Tissue, and Gene Therapies |
| August 26, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 26, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 17, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Minaris Regenerative Medicine, LLC
- FDA Inspection 1284408 - 2025-09-29
- FDA Inspection 1101234 - 2019-08-26
- FDA Inspection 1020396 - 2017-04-26
- FDA Inspection 886646 - 2014-06-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.